Market Research Reports and Industry Reports

Enterprise Therapeutics Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

Enterprise Therapeutics Ltd (Enterprise Therapeutics) is a drug discovery company which focuses on the research and development of novel therapies for the treatment of respiratory diseases. It also identifies novel targets and compounds which reduces the mucus production. The company focuses in the therapeutic areas of chronic obstructive pulmonary disease (COPD), cystic fibrosis and severe asthma. Enterprise Therapeutics holds expertise in drug discovery, drug development, respiratory biology and ion channel pharmacology. It also operates with offices in Cambridge and at the University of Sussex. The company was backed by Epidarex Capital and Imperial Innovations. Enterprise Therapeutics is headquartered in Brighton, England, the UK.

Enterprise Therapeutics Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Enterprise Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Enterprise Therapeutics Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Enterprise Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Enterprise Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Enterprise Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Enterprise Therapeutics Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Enterprise Therapeutics Raises USD5 Million in Venture Financing 10
Enterprise Therapeutics Raises Additional USD3.8 Million in Series A Financing 11
Enterprise Therapeutics Raises USD2.4 Million in Series A Financing 12
Enterprise Therapeutics Ltd - Key Competitors 13
Enterprise Therapeutics Ltd - Key Employees 14
Enterprise Therapeutics Ltd - Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Corporate Communications 16
Oct 17, 2016: Enterprise Therapeutics Appoints Dr John Ford as CEO 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List Of Tables


Enterprise Therapeutics Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Enterprise Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Enterprise Therapeutics Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Enterprise Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Enterprise Therapeutics Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Enterprise Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Enterprise Therapeutics Raises USD5 Million in Venture Financing 10
Enterprise Therapeutics Raises Additional USD3.8 Million in Series A Financing 11
Enterprise Therapeutics Raises USD2.4 Million in Series A Financing 12
Enterprise Therapeutics Ltd, Key Competitors 13
Enterprise Therapeutics Ltd, Key Employees 14

List Of Figures


Enterprise Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2
Enterprise Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2
Enterprise Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2
Enterprise Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 2
Enterprise Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Enterprise Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Enterprise Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Enterprise Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Asia-Pacific Enterprise Wearable Market Report 2017

In this report, the Asia-Pacific Enterprise Wearable market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing

USD 4000View Report

EMEA (Europe, Middle East and Africa) Enterprise Wireless Local Area Network Market Report 2017

In this report, the EMEA Enterprise Wireless Local Area Network market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end

USD 4000View Report

Re-Vana Therapeutics Ltd - Medical Equipment - Deals and Alliances Profile

Re-Vana Therapeutics Ltd (Re-Vana) is an ocular pharmaceutical and drug delivery company with focus on the development and commercialization of biodegradable long- acting drug delivery platforms to treat ophthalmic conditions.

USD 250View Report

Leap Therapeutics Ltd (MCUR) - Financial and Strategic SWOT Analysis Review

This comprehensive SWOT profile of Leap Therapeutics Ltd provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to

USD 300View Report

Fill The Form For Sample Request
Name*
Email*
Mobile No.*
LandLine No.
Country Code.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Aug 2017
No. of Pages :17
Country :United Kingdom
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment
  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube